Join to view full profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-359-8111
Fax+1 626-408-3911
Dr. Luu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
UMass Chan - BaystateResidency, Internal Medicine, 1998 - 2000
UMass Chan Medical SchoolInternship, Internal Medicine, 1996 - 1997- University of Massachusetts Medical SchoolClass of 1996
Certifications & Licensure
CA State Medical License 2003 - 2026
Clinical Trials
- Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
- Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery Start of enrollment: 2006 Jun 12
- Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer
Publications & Presentations
PubMed
- 29 citationsPhase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancerJin Sun Lee, Susan E. Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Holly Yin
Breast Cancer Research. 2019-11-08 - 32 citationsMutation and immune profiling of metaplastic breast cancer: Correlation with survival.Michelle Afkhami, Daniel Schmolze, Susan E. Yost, Paul Frankel, Andrew Dagis
Plos One. 2019-11-06 - 11 citationsPhase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.Thehang Luu, Paul Frankel, Jan H. Beumer, Dean Lim, Mihaela C. Cristea
Cancer Chemotherapy and Pharmacology. 2019-09-14
Press Mentions
OncoGambit Increases Chances of Cancer Survival Rates and Relieves Patient Anxiety Through User-Friendly, Treatment Confirmation PlatformNovember 15th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
